Loading...
146 Middle East and Africa Active Pharmaceutical Ingredients Reports
Country Covered: Saudi Arabia
Study Period: 2019 - 2029
Major Players: Pfizer, Inc., Aurobindo Pharma, Novartis AG, BASF SE, Viatris Inc.
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: South Africa, Saudi Arabia, Oman, Egypt, Iran
Major Players: Takeda, Pfizer, Bayer, SunPharma, Glenmark
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Astrazeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Astellas
Region Covered: Middle East and Africa
Study Period: 2019- 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Merck, Novartis, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company
Region Covered: Middle East and Africa
Study Period: 2019- 2029
Countries Covered: Saudi Arabia, Egypt, Iran, South Africa, Oman
Major Players: AstraZeneca, Sanofi, Eli Lilly and Company, Novo Nordisk A/S, Pfizer Inc.
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: South Africa, Saudi Arabia, Oman, Egypt, Iran
Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon
Region Covered: Middle East and Africa
Study Period: 2019- 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Novo Nordisk, Sanofi, Eli lilly, Wockhardt, Pfizer
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Mankind Pharma, Pfizer Inc, Dr.Morepen, Smith & Nephew Plc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc. , AA Pharma Inc. , GSK plc, Viatris Inc, Teva Pharmaceutical Industries Ltd
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: ACG Worldwide, Capscanada Corporation, Medi-Caps Ltd, Bright Pharma Caps Inc, Lonza Group(Capsugel)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Bayer, Reckitt Benckiser Group plc, GlaxoSmithKline plc, Pfizer
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: GlaxoSmithKline plc, Amgen Inc., Novartis AG, AbbVie Inc., F. Hoffmann-La Roche AG
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Baxter International Inc., Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer Inc.
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Merck & Co, Inc., GlaxoSmithKline plc (ViiV Healthcare)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Baxter, Lunan Pharmaceutical Group Co. Ltd, Piramal Enterprises Limited, Fresenius Kabi, Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Thermo Fisher Scientific Inc., Sanofi (EUROAPI), Teva Pharmaceutical Industries Ltd, Merck KGaA
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Santen Pharmaceutical Co., Ltd.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Zydus Cadila, Aurobindo Pharma
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: AbbVie Inc , Amgen Inc , Cadila Healthcare Ltd , Hetero Healthcare Limited, Pfizer Inc
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Amgen, Pfizer, AbbVie Inc, Teva Pharmaceuticals
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie, Inc, Johnson and Johnson, Novartis AG, Eli Lilly and Company, GlaxoSmithKline Plc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, United Kingdom, France, Germany, Italy, Spain, India, China, Japan, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, AstraZeneca PLC, Bayer Ag, Boehringer Ingelheim International GmbH, Amgen Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Merck & Co., Inc, Gilead Sciences, GlaxoSmithKline PLC, Pfizer Inc, Novartis AG
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Bayer AG, Merck & Co., Inc., Glenmark Pharmaceuticals Limited, GSK plc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Johnson and Johnson , Baxter International Inc. (Avante Health Solutions)
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Abbvie Inc., Silvergate Pharmaceuticals Inc., Novartis AG, GlaxoSmithKline
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: GlaxoSmithKline PLC, Sanofi, AstraZeneca, Eli Lilly and Company, Pfizer Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly & Co. , Apotex Inc. , Fressenius Kabi USA, Mylan Pharmaceuticals Inc., Pfizer Inc. (Hospira Inc.)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Astellas Pharma, Inc, Sanofi (Genzyme), Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer, Teva Pharmaceuticals, Zydus Cadila, Ipsen Biopharmaceuticals Inc., Neurana Pharmaceuticals
Filter Reports
By Countries
